Alvotech (ALVO) Cash from Financing Activities (2023 - 2026)

Alvotech (ALVO) posted Cash from Financing Activities of -$967000.0 for Q1 2026, down 100.36% on a QoQ basis from $270.8 million in Q4 2025, and up 83.44% year-over-year from -$527150.9 in Q1 2025.

Alvotech (ALVO) Cash from Financing Activities (2023 - 2026) Analysis & Trends

Alvotech's Cash from Financing Activities history runs 4 years deep, the most recent figure standing at -$967000.0 for Q1 2026.

  • Quarterly Cash from Financing Activities rose 83.44% year-over-year to -$967000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $275.7 million (up 74.18% YoY) and the FY2025 annual result came in at $270.8 million, down 8.9% from the prior year.
  • Cash from Financing Activities was -$967000.0 for Q1 2026 at Alvotech, down from $270.8 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $297.0 million in Q4 2024 and bottomed at -$136.9 million in Q3 2024.
  • A 4-year average of $61.0 million and a median of $12.3 million in 2023 frame the typical range for Cash from Financing Activities.
  • Peak annual rise in Cash from Financing Activities reached 1977.64% in 2025, while the deepest fall reached 104.38% in 2025.
  • Alvotech's Cash from Financing Activities stood at $20.7 million in 2023, then surged by 1337.55% to $297.0 million in 2024, then dropped by 8.84% to $270.8 million in 2025, then sank by 100.36% to -$967000.0 in 2026.
  • Business Quant data shows ALVO's Cash from Financing Activities at -$967000.0 in Q1 2026, $270.8 million in Q4 2025, and -$77.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Alvotech 935.87 Mn 935.87 Mn 5.09 Mn -967,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -967,000.00
Mar 31, 2026 -967,000.00
Dec 31, 2025 270.77 Mn
Dec 31, 2025 270.77 Mn
Sep 30, 2025 -77.24 Mn
Sep 30, 2025 -77.24 Mn
Jun 30, 2025 83.15 Mn
Jun 30, 2025 83.15 Mn
Mar 31, 2025 -5.84 Mn
Mar 31, 2025 -5.84 Mn
Dec 31, 2024 297.01 Mn
Dec 31, 2024 297.01 Mn
Sep 30, 2024 -136.89 Mn
Sep 30, 2024 -136.89 Mn
Jun 30, 2024 4.00 Mn
Jun 30, 2024 4.00 Mn
Mar 31, 2024 133.18 Mn
Mar 31, 2024 133.18 Mn
Dec 31, 2023 20.66 Mn
Dec 31, 2023 20.66 Mn